Overview
- 13 inspections across 13 sites are on record.
- 24 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-04.
At a glance
Inspections
13
Sites
13
Observations
24
Career since
Jan 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Direct Rx | 4 Jun 2026 | Human Drugs | |
| Omega & Delta Co., Inc. | 20 Mar 2026 | Human Drugs | View 483 → |
| Ingenus Pharmaceuticals NJ, LLC. | 9 Jan 2026 | Human Drugs | |
| Indiana Botanic Gardens, Inc | 30 Sep 2025 | Human Drugs | View 483 → |
| Dee Cee Laboratories, Inc | 11 Aug 2025 | Human Drugs | View 483 → |
Sites inspected
Direct RxDawsonville, United States1 insp.
Omega & Delta Co., Inc.Carolina, United States1 insp.
Ingenus Pharmaceuticals NJ, LLC.Fairfield, United States1 insp.
Indiana Botanic Gardens, IncHobart, United States1 insp.
Dee Cee Laboratories, IncWhite House, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Tanya R Syffrard2 shared
Veronica Fuentes2 shared
Alisha B Patel1 shared
Nelson N Ayangho1 shared
Andrew O Ejiofor1 shared
Samantha E Cleek1 shared
Inga M Warr1 shared
Anthony J Donato1 shared
JoshRenzo N Ramilo1 shared
Pamela N Agaba1 shared
Full investigator report
Get the verbatim findings behind Tomika L Crafter's 24 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site